日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers

老年不可切除局部晚期非小细胞肺癌患者接受每日低剂量卡铂同步放化疗：临床结果及全身炎症标志物的预后意义

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33030135
Miura, Yu; Imai, Hisao; Endo, Satoshi; Hashimoto, Kosuke; Yamaguchi, Ou; Mouri, Atsuto; Masubuchi, Ken; Masubuchi, Takeshi; Fujita, Yuka; Kato, Shingo; Kagamu, Hiroshi; Kaira, Kyoichi
肺癌
肿瘤
炎症
肿瘤免疫
炎症/感染
Immunology/Inflammation
细胞生物学
发表日期：2026
文献求助 收藏

A strong association between TTF-1 expression and interstitial lung disease in predicting the efficacy of PD-1 inhibitor for nonsquamous NSCLC patients

TTF-1表达与间质性肺病之间存在密切关联，可用于预测PD-1抑制剂对非鳞状非小细胞肺癌患者的疗效

期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00628-2024
Ito, Masaru; Honda, Takayuki; Onishi, Iichiroh; Endo, Satoshi; Mochizuki, Akifumi; Nishiyama, Naoki; Sakakibara, Rie; Takahashi, Susumu; Kumagai, Takashi; Hata, Koki; Yoshii, Sao; Nakamura, Kentaro; Yamashita, Takaaki; Tsukada, Yoshikazu; Chiaki, Tomoshige; Miyashita, Yoshihiro; Natsume, Ichirou; Saitou, Kazuhito; Miyazaki, Yasunari
肺癌
肿瘤
特发性肺纤维化
肿瘤免疫
细胞生物学
PD-1
发表日期：2025
文献求助 收藏

Estimating motor symptom presence and severity in Parkinson's disease from wrist accelerometer time series using ROCKET and InceptionTime

利用 ROCKET 和 InceptionTime，根据腕部加速度计时间序列数据评估帕金森病患者的运动症状及其严重程度

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-04263-2
Donié, Cedric; Das, Neha; Endo, Satoshi; Hirche, Sandra
ROCK
帕金森
神经科学
发表日期：2025
文献求助 收藏

A Real-Word Analysis of the Correlation Between Clinical Efficacy and Predictive Factors of Immune-Related Adverse Events in Patients With Nonsmall Lung Cancer Treated With Nivolumab Plus Ipilimumab

一项关于纳武利尤单抗联合伊匹木单抗治疗非小细胞肺癌患者临床疗效与免疫相关不良事件预测因素相关性的真实世界分析

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70741
Mouri, Atsuto; Imai, Hisao; Endo, Satoshi; Nakagawa, Junichi; Tsukamoto, Kasumi; Kurata, Yuhei; Yamaguchi, Ou; Masaki, Kenji; Hashimoto, Kosuke; Shiono, Ayako; Miura, Yu; Kobayashi, Kunihiko; Kaira, Kyoichi; Kagamu, Hiroshi
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer

一线纳武利尤单抗联合伊匹木单抗治疗老年（≥75岁）非小细胞肺癌患者的疗效和安全性

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06089-x
Endo, Satoshi; Imai, Hisao; Mouri, Atsuto; Tsukamoto, Kasumi; Masaki, Kenji; Hashimoto, Kosuke; Miura, Yu; Shiono, Ayako; Yamaguchi, Ou; Nakagawa, Junichi; Kaira, Kyoichi; Kobayashi, Kunihiko; Kagamu, Hiroshi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

MSC and HUVEC co-cultured fillers overcome intractable fistula in a new mouse model.

MSC 和 HUVEC 共培养的填充物在新小鼠模型中克服了顽固性瘘管

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0330478
Hirasawa Soichiro, Murakami Kentaro, Kano Masayuki, Endo Satoshi, Toyozumi Takeshi, Matsumoto Yasunori, Otsuka Ryota, Sekino Nobufumi, Shiraishi Tadashi, Ryuzaki Takahiro, Kinoshita Kazuya, Sasaki Takuma, Matsubara Hisahiro
其它
Mouse
发表日期：2025
文献求助 收藏

Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational Study

一线纳武利尤单抗联合伊匹木单抗治疗术后复发和不可切除的非小细胞肺癌患者的疗效和安全性：一项真实世界回顾性观察研究

期刊:Medicina-Lithuania
影响因子:2.4
doi:10.3390/medicina61060994
Kurata, Yuhei; Mouri, Atsuto; Imai, Hisao; Endo, Satoshi; Tsukamoto, Kasumi; Masaki, Kenji; Hashimoto, Kosuke; Miura, Yu; Shiono, Ayako; Yamaguchi, Ou; Nakagawa, Junichi; Kaira, Kyoichi; Kobayashi, Kunihiko; Kagamu, Hiroshi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Repetitive Grasping After Stroke Assisted by Functional Electrical Stimulation

中风后重复性抓握障碍的治疗：功能性电刺激辅助治疗

期刊:Artificial Organs
影响因子:2.3
doi:10.1111/aor.15033
Höhler, Chiara; Endo, Satoshi; Hermsdörfer, Joachim; Cazenave, Lucille; Kavianirad, Hossein; Jahn, Klaus; Krewer, Carmen
中风
心血管
发表日期：2025
文献求助 收藏

Significance of Platinum-Based Chemotherapy With Programmed Death-1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective Study

铂类化疗联合程序性死亡受体1（PD-1）阻断治疗局限期小细胞肺癌的意义：一项回顾性研究

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.70118
Shiono, Ayako; Imai, Hisao; Kaira, Kyoichi; Abe, Takanori; Sato, Yuki; Yamamoto, Ken; Watanabe, Hiroki; Tsuchiya-Kawano, Yuko; Tamiya, Akihiro; Osaki, Takashi; Yanagitani, Noriko; Tanzawa, Shigeru; Sumi, Toshiyuki; Yoshimine, Kohei; Matsui, Yohei; Endo, Satoshi; Shibata, Kazuhiko; Takemoto, Shinnosuke; Miura, Yosuke; Nagai, Yoshiaki; Nakagawa, Junichi; Tsuda, Takeshi; Kagamu, Hiroshi
肺癌
肿瘤
肿瘤免疫
信号转导
细胞生物学
PD-1
发表日期：2025
文献求助 收藏

Clinical significance of post‑progression survival after chemoradiotherapy on overall survival in limited‑disease small cell lung cancer

化疗放疗后疾病进展生存期对局限期小细胞肺癌总生存期的临床意义

期刊:Molecular and Clinical Oncology
影响因子:1.4
doi:10.3892/mco.2025.2853
Shiono, Ayako; Imai, Hisao; Endo, Satoshi; Okazaki, Shohei; Abe, Takanori; Mouri, Atsuto; Kaira, Kyoichi; Masubuchi, Ken; Kobayashi, Kunihiko; Minato, Koichi; Kato, Shingo; Kagamu, Hiroshi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏